WCLC 2022 Conference Coverage


 

WCLC 2022 on the Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ Disease

71 views
August 18, 2022
0 Comments
Login to view comments. Click here to Login
Videos